HIV pre-exposure prophylaxis (PrEP) is no longer a one-size-fits-all approach. Today, multiple options and dosage forms exist to offer individualized protection for the 1.2 million people in the United States for whom PrEP is recommended. As medication experts of the health care team, pharmacists need to be able to educate patients and prescribers alike on the indications, safety, efficacy, administration, and prescribing requirements of new PrEP agents. However, surveys of learning and confidence across the United States reveal that approximately 50%-70% of practicing pharmacists lack sufficient knowledge to counsel on PrEP therapy.
In part 2 of this CMEO podcast series, New Horizons in HIV Prevention Education: A Closer Look at Novel Therapies, join Drs. Milena Murray and Dan Scales as they review recent advances in HIV prevention products and address knowledge gaps in the HIV health care continuum.
At the end of this CME/CE activity, participants should be able to evaluate the efficacy and safety data for current and emerging PrEP to optimize long-term outcomes for patients and improve the continuum of care.
Supported by an educational grant from Gilead Sciences, Inc. This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the developmental content or selection of faculty for this educational activity.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.
Dr. Scales reports no financial relationships.
Dr. Murray reports the following financial relationships: Advisory Board: Janssen Pharmaceuticals, Inc.; Theratechnologies Inc; and ViiV Healthcare Speakers Bureau: Merck & Co., Inc.
The following CME Outfitters Staff have no financial relationships to disclose:
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Call us at (877) CME-PROS or (877) 263-7767.